Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro
Izabela Zakrocka(Medical University of Lublin), Waldemar A. Turski(Medical University of Lublin), Katarzyna M. Targowska‐Duda(Medical University of Lublin), Artur Wnorowski(Medical University of Lublin), Tomasz Kocki(Medical University of Lublin), Krzysztof Jóźwiak(Medical University of Lublin)
Cited by 10
Related Papers
Kynurenine pathway in kidney diseases
|Pharmacological Reports|2021|53
Increased expression of kynurenine aminotransferases mRNA in lymphocytes of patients with inflammatory bowel disease
|Therapeutic Advances in Gastroenterology|2019|42
Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications
|Neurotoxicity Research|2017|36
Matrix metalloproteinases and atherosclerosis
|Postępy Higieny i Medycyny Doświadczalnej|2011|34
Effects of systemic administration of kynurenic acid and glycine on renal haemodynamics and excretion in normotensive and spontaneously hypertensive rats
|European Journal of Pharmacology|2014|26